DAYTONA BEACH, Fla. (GenomeWeb) – Clinical diagnostics firm Quidel described improvements it has made to its Solana molecular testing platform, and outlined future menu goals and possible platform improvements during a company-sponsored corporate workshop at the Clinical Virology Symposium here this week.

In addition, independent researchers presented preliminary data on a clinical trial of Quidel's AmpliVue Trichomonas assay and described novel sample types that might be used with the company's tests in the future.